Hideki Ueno
*Hepatobiliary and Pancreatic Oncology Division
National Cancer Center Hospital
5-1-1 Tsukiji
Chuo-ku
Japan
Name/email consistency: high
- Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer. Ueno, H., Okusaka, T., Furuse, J., Yamao, K., Funakoshi, A., Boku, N., Ohkawa, S., Yokosuka, O., Tanaka, K., Moriyasu, F., Nakamori, S., Sato, T. Jpn. J. Clin. Oncol. (2011)
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Ueno, H., Kosuge, T., Matsuyama, Y., Yamamoto, J., Nakao, A., Egawa, S., Doi, R., Monden, M., Hatori, T., Tanaka, M., Shimada, M., Kanemitsu, K. Br. J. Cancer (2009)
- Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients. Ueno, H., Kaniwa, N., Okusaka, T., Ikeda, M., Morizane, C., Kondo, S., Sugiyama, E., Kim, S.R., Hasegawa, R., Saito, Y., Yoshida, T., Saijo, N., Sawada, J. Br. J. Cancer (2009)
- Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Ueno, H., Kiyosawa, K., Kaniwa, N. Br. J. Cancer (2007)
- Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer. Ueno, H., Okusaka, T., Ikeda, M., Morizane, C., Ogura, T., Hagihara, A., Tanaka, T. Jpn. J. Clin. Oncol. (2007)
- Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C. Ueno, H., Sato, T., Yamamoto, S., Tanaka, K., Ohkawa, S., Takagi, H., Yokosuka, O., Furuse, J., Saito, H., Sawaki, A., Kasugai, H., Osaki, Y., Fujiyama, S., Sato, K., Wakabayashi, K., Okusaka, T. Cancer Sci. (2006)
- A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer. Ueno, H., Okusaka, T., Ikeda, M., Ishiguro, Y., Morizane, C., Matsubara, J., Furuse, J., Ishii, H., Nagase, M., Nakachi, K. Oncology (2005)
- Phase II study of S-1 in patients with advanced biliary tract cancer. Ueno, H., Okusaka, T., Ikeda, M., Takezako, Y., Morizane, C. Br. J. Cancer (2004)
- Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer. Ueno, H., Okusaka, T., Ikeda, M., Tokuuye, K. Oncology (2004)
- Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma. Ueno, H., Okada, S., Okusaka, T., Ikeda, M., Kuriyama, H. Cancer Chemother. Pharmacol. (2002)
- Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer. Ueno, H., Okada, S., Okusaka, T., Ikeda, M., Kuriyama, H. Oncology (2002)
- Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Ueno, H., Okada, S., Okusaka, T., Ikeda, M., Tanaka, N., Sakamoto, M., Yoshimori, M. Hepatogastroenterology (2001)
- Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Ueno, H., Okada, S., Okusaka, T., Ikeda, M. Oncology (2000)
